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The embryonic programme ‘epithelial–mesenchymal transition’
(EMT) is thought to promote malignant tumour progression. The
transcriptional repressor zinc-finger E-box binding homeobox 1
(ZEB1) is a crucial inducer of EMT in various human tumours, and
was recently shown to promote invasion and metastasis of
tumour cells. Here, we report that ZEB1 directly suppresses
transcription of microRNA-200 family members miR-141 and
miR-200c, which strongly activate epithelial differentiation in
pancreatic, colorectal and breast cancer cells. Notably, the EMT
activators transforming growth factor b2 and ZEB1 are the
predominant targets downregulated by these microRNAs. These
results indicate that ZEB1 triggers an microRNA-mediated
feedforward loop that stabilizes EMT and promotes invasion of
cancer cells. Alternatively, depending on the environmental
trigger, this loop might switch and induce epithelial differentia-
tion, and thus explain the strong intratumorous heterogeneity
observed in many human cancers.
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INTRODUCTION
Increasing evidence indicates that aberrant activation of the
embryonic programme ‘epithelial–mesenchymal transition’ (EMT)
promotes tumour cell invasion and metastasis (Berx et al, 2007).
EMT allows detachment of cells from each other and increases cell
mobility, both of which are necessary for tumour cell dissemina-
tion. Metastases often recapitulate the differentiated phenotype of
the primary tumour; therefore, EMT seems to be transiently
activated by the inductive tumour environment at the invasive
tumour edge, but is reversed in growing metastases (Brabletz et al,
2001, 2005). Activators of EMT, such as transforming growth
factor (TGF)b, tumour necrosis factor a (TNFa) and hepatocyte
growth factor, are produced by infiltrating cells or the tumour cells
themselves, and trigger expression of EMT-inducing transcrip-
tional repressors (Thiery & Sleeman, 2006). These include
members of the Snail family, the basic helix–loop–helix family,
Goosecoid and members of the ZFH family (zinc-finger E-box
binding homeobox (ZEB)1 and ZEB2; Barrallo-Gimeno & Nieto,
2005; Hugo et al, 2007; Peinado et al, 2007). Recently, we
described that ZEB1 is a crucial EMT activator in human colorectal
and breast cancer, and suppresses expression of basement
membrane components (Spaderna et al, 2006) and cell polarity
factors (Aigner et al, 2007; Spaderna et al, 2008). Expression of
ZEB1 promotes metastasis of tumour cells in a mouse xenograft
model, indicating a role of ZEB1 in invasion and metastasis of
human tumours (Spaderna et al, 2008).
MicroRNAs (miRNAs) are small non-coding RNAs that can
silence their cognate target genes by specifically binding and
cleaving messenger RNAs or inhibiting their translation (Bartel,
2004). miRNAs regulate diverse cellular processes and some
miRNAs have been shown to function as either tumour
suppressors or oncogenes (Esquela-Kerscher & Slack, 2006).
Recent important examples are the oncogenic miR-10b, which
promotes metastasis (Ma et al, 2007), and miR-335/miR-126,
which suppress metastasis in breast cancer (Tavazoie et al, 2008).
Owing to these important regulatory functions of miRNAs, it is
of prime interest to know how their expression is regulated by
upstream factors. Here, we address this point and focus on
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582the activation and stabilization of EMT in cancer cells. We
investigated whether aberrant expression of the crucial EMT
activator ZEB1 and the control of potential EMT-regulatory
miRNAs are linked and can synergize to promote malignant
tumour progression.
RESULTS
ZEB1 directly suppresses transcription of miRNAs
TGFb and TNFa have been shown to induce an EMT in
differentiated colorectal cancer cells (Bates et al, 2005). We
observed activation of EMT in differentiated pancreatic (HPAF2),
colorectal (DLD1) and breast cancer (MCF7) cell lines by TGFb/
TNFa. Thus, ZEB1 was a crucial intracellular transmitter of this
EMT, as its expression was upregulated by both cytokines and its
knockdown partly prevented EMT (supplementary Fig 1A,B
online). Direct epithelial target genes suppressed by ZEB1, such
as E-cadherin, cell polarity factors and basement membrane
components, have been described previously (Grooteclaes &
Frisch, 2000; Aigner et al, 2007; Spaderna et al, 2008). Here, we
investigated whether ZEB1 also affects expression of miRNAs and
if detected miRNAs themselves are candidate regulators of EMT.
A miRNA expression microarray screen was used to analyse
SW480 and HCT116 colorectal and MDA-MB231 breast cancer
cell clones with stable short hairpin RNA-mediated knockdown of
ZEB1 (shZEB clones) in comparison with control knockdown
(shCtl) clones. We have shown previously that stable knockdown
of ZEB1 in these clones led to a reversal of the fibroblastoid
phenotype towards an epithelial differentiation in the sense of a
mesenchymal–epithelial transition (Spaderna et al, 2008). Out of
743 human, rat and mouse miRNAs included on the microarray
screen, we detected average upregulation (41.75-fold) after ZEB1
knockdown of 79 miRNAs (10.59%) in at least one cell line, 17
miRNAs (2.27%) in two cell lines and only 4 miRNAs (0.53%)
in all three cell lines (Fig 1; supplementary Table 1 online). The
strongest effect was observed for the undifferentiated breast cancer
cell line MDA-MB231. Notably, three of the four miRNAs
upregulated in all cell lines (miR-141, miR-200b and miR-200c)
belong to the highly conserved miRNA-200 family, which was
recently linked to the induction of epithelial differentiation
(Hurteau et al, 2007; Gregory et al, 2008; Park et al, 2008).
Further analyses focused on miR-141 and miR-200c, which
showed strongest upregulation after knockdown of ZEB1 in all
three cancer cell lines.
The array data were validated by using real-time PCR for
miR-141 and miR-200c, which showed a strong increase after
knockdown of ZEB1 in undifferentiated pancreatic, colorectal and
breast cancer cell lines (supplementary Fig 1C online). Next, we
investigated whether ZEB1 directly suppresses transcription of the
miR-141 and miR-200c miRNA genes. Both miRNAs map closely
on human chromosome 12p13.31 and the stem–loop sequences
are separated by only a 338-base-pair spacer sequence (Fig 2A).
This spacer and the putative promoter 600bp upstream from the
hsa-miR-200c stem–loop contain six putative binding sequences
for ZEB1, two of which were restricted to ZEB factors (Z-box 1 and 2,
CAGGTA). The remaining four were perfect E-boxes (E-box 1–4,
CAGGTG), which, in addition to ZEB1, represent putative binding
sites for other EMT activators, such as Snail factors. Note that the
overall miRNA gene structure and the two Z-boxes, as well as
E-box 2, are highly conserved in evolution from zebrafish to
human (Fig 2A). All the conserved ZEB1-binding sequences are
located within the putative promoter, whereas the two E-boxes in
the spacer sequence are not conserved. After cloning of the
putative promoter ( 683 to  67 relative to first nucleotide of
the miR-200c stem–loop) and the spacer (þ66 to þ338) into a
luciferase reporter vector, ZEB1-dependent activity was assessed.
shRNA-mediated knockdown of ZEB1 in all undifferentiated
colorectal, breast and pancreatic cancer cell lines tested resulted
in an enhanced promoter activity when compared with shCtl cell
clones (Fig 2B, left). On the contrary, the promoter activity was
suppressed by ZEB1 overexpression in a dose-dependent manner.
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miRNA Mean expression Mean expression Mean expression
hsa-miR-141    1,945 55,064 28.02 5,881 13,864 2.36 7,440 31,735 4.27
hsa-miR-200c   2,592 35,739 13.79 6,510 14,836 2.28 14,033 29,841 2.13
hsa-miR-200b   4,007 40,792 10.18 23,896 42,317 1.77 20,686 45,983 2.22
hsa-miR-182    1,575 8,581 5.45 2,849 5,522 1.94 3,297 6,388 1.93
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Fig 1 |Knockdown of ZEB1 enhances expression of microRNAs. Growth patterns and staining for E-cadherin and b-catenin of characteristic short
hairpin control (shCtl) and shZEB1 knockdown clones of breast (MDA-MB231) and colorectal (SW480 and HCT116) cancer cell lines used for the
microRNA (miRNA) expression array screen. The mean relative ZEB1 expression levels of each two clones are indicated. The mean miRNA expression
values (two hybridizations of each two independent sh control or shZEB1 clones per cell line) are shown. Knockdown of ZEB1 resulted in upregulation
of the indicated miRNAs in all three cell lines. ZEB1, zinc-finger E-box binding homeobox 1.
ZEB1 induces a miRNA-mediated regulatory loop
U. Burk et al
&2008EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 9 | NO 6 | 2008
scientificreport
583Similar effects, although to a lesser extent, were also observed
after Snail1 overexpression, which can bind to only two of the four
potential ZEB1-binding sites within the putative promoter (Fig 2B,
middle). The expression level of ZEB1 had no significant effect on
the transcriptional activity of the spacer sequence. Mutation of the
two highly conserved Z-boxes showed that Z-box 2 confers the
strongest repressive function by ZEB1 (Fig 2B, right) and also made
the promoter activity insensitive to stable knockdown of ZEB1
(supplementary Fig 1D online). A direct binding of ZEB1 to the
two conserved ZEB1 sites (Z-boxes) was shown by electromobility
shift assay by using recombinant DNA-binding domain of ZEB1
and nuclear extracts from SW480 colorectal cancer cells (Fig 2C).
By applying chromatin immunoprecipitation (ChIP) with chroma-
tin from SW480 or HCT116 colorectal cancer cells, we could
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584b Fig 2 |ZEB1 directly suppresses transcription of miR-141 and miR-200c. (A) Schematic of the genomic organization of hsa-miR-141 and hsa-miR-200c
on chromosome 12p13.31, and alignment of the highly conserved Z- and E-boxes. The putative ZEB1 binding sites, the cloned promoter and spacer
sequence, as well as the region amplified for ChIP, are indicated. All numbers are relative to the start of the hsa-miR-200c stem–loop sequence.
(B) Left panel: stable ZEB1 knockdown in the indicated undifferentiated colorectal (SW480), breast (MDA-MB231) and pancreatic (Panc-1) cell clones
enhances the activity of the putative promoter, but does not or only weakly enhances the activity of the spacer sequence. The mean values of the
corresponding short hairpin control (shCtl) clones were set to 1. Middle panel: overexpression of ZEB1 and to a lesser extent that of Snai1 in HCT116
cells repress the activity of the promoter but not the spacer sequence in a dose-dependant manner. The absolute transcriptional activity of the
promoter was 55-fold higher than the activity of the spacer sequence. Right panel: mutations (mut) of the Z-boxes render the promoter less sensitive
to suppression by ZEB1. (C) Electromobility shift assay using recombinant DNA-binding domain of ZEB1 (left panel) or nuclear extracts from SW480
colorectal cancer cells (right panel) and the indicated labelled probes. Mutation of the two conserved Z-boxes (Z1, Z2) strongly reduced the specific
binding complex (asterisk). Three different antisera against ZEB1, but not control serum, supershifted (arrow) a specific complex (asterisk), which is
missing in the mutated probes, indicating that it contains ZEB1. The known ZEB1-binding site of the interleukin-2 promoter (NRE) was used as a
positive control. (D) ChIP with two different ZEB1 antisera shows in vivo binding of ZEB1 to the putative promoter in the indicated colorectal cancer
cell lines. ChIP, chromatin immunoprecipitation; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; WT, wild type; ZEB1, zinc-finger E-box binding
homeobox 1.
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Fig 3 |miR-141 and miR-200c induce mesenchymal–epithelial transition. (A) Overexpression of both microRNAs (miRNAs) in undifferentiated
cancer cell lines induces a mesenchymal–epithelial transition, indicated by upregulation of E-cadherin (green), partial membranous translocation of
E-cadherin and restoration of basal–apical polarity (see z-mode). The effect was stronger for miR-200c and comparable with the effect of a ZEB1
knockdown. (B) Upper panel: miR-200c suppressed migration of MDA-MB231 cells. Lower panels: picture and quantification of a Matrigel invasion
assay. Transfection with miR-200c strongly suppressed invasion of MDA-MB231 into Matrigel, comparable with short interfering (si) RNA-mediated
knockdown of ZEB1. (C) Differentiated cancer cell lines transfected with miRNA inhibitors against miR-141 and miR-200c show increased cell
scattering, upregulation of vimentin (HPAF2) or reduced expression of E-cadherin (DLD1). By contrast, the epithelial phenotype induced by stable
knockdown of ZEB1 (SW480 shZEB1) cannot be reversed by miRNA inhibitors. sh, short hairpin; ZEB1, zinc-finger E-box binding homeobox 1.
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585show that endogenous ZEB1 binds to the native promoter region
(Fig 2D). These data indicate that the transcriptional repressor
ZEB1 can directly suppress expression of both miR-141 and
miR-200c by binding to their putative common promoter.
miRNAs targeted by ZEB1 are inhibitors of EMT
Next, we investigated whether the two miRNAs suppressed by
ZEB1 represent direct EMT regulators. We showed that miR-200c
and miR-141 are strong inducers of an epithelial phenotype,
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Fig 4 |miR-141 and miR-200c reduce expression of factors promoting epithelial–mesenchymal transition and invasion. (A) Predicted duplex formation
of TGFb23 0UTR with the miR-141 stem–loop and of two ZEB1 30UTR regions with the miR-200c stem–loop. The putative recognition sites are highly
conserved among various species. (B) Real-time reverse transcription–PCR of various putative target factors after transfection of the indicated miRNAs
or short interfering (si) RNA in undifferentiated cancer cells. Note strongest reduction of TGFb2 expression after miR-141 transfection and that of
ZEB1 after miR-200c transfection. (C) Confirmation of the results on protein levels by immunoblots. (D) Luciferase reporter assay showing reduced
activity of 30UTR-luciferase reporter constructs in the indicated SW480 short hairpin ZEB1 (shZEB1) clones with increased levels of miR-141 and
miR-200c compared with shCtl clones. (E) Overexpression of miR-141 and miR-200c in SW480 cells leads to decreased activity of TGFb23 0UTR-
luciferase and ZEB1 30UTR-luciferase constructs, respectively. (F) Model of a feedforward loop linking ZEB1 and counteracting miRNAs, in particular
miR-200c. As ZEB1 and both miRNAs repress each other, they are linked in a feedforward loop. Depending on the initial signal, this loop could
stabilize either mesenchymal or epithelial differentiation. In tumours, environmental TGFb could trigger upregulation of ZEB1, promoting a self-
enhancing loop in tumour cells, finally resulting in EMT and invasion. Once the initial signal breaks down, the loop could induce a reversal of the
epithelial phenotype. This might explain the strong phenotypic heterogeneity often seen within individual tumours and metastases. EMT, epithelial–
mesenchymal transition; MET, mesenchymal–epithelial transition; miRNA, microRNA; TGF, transforming growth factor; UTR, untranslated region;
ZEB1, zinc-finger E-box binding homeobox 1.
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586which was also recently reported by other groups during the
course of our work (Hurteau et al, 2007; Gregory et al, 2008; Park
et al, 2008). Transient overexpression of both miR-141 and
miR-200c resulted in the induction of epithelial differentiation
of undifferentiated cancer cells (Fig 3A; supplementary Fig 2A,B
online). In particular, the overall effect of miR-200c was
comparable with the strong effect of ZEB1 knockdown. Notably,
miR-200c, and to a lesser extent miR-141, also led to increased
E-cadherin expression and cell–cell adhesion, as well as reduced
spreading of normal human fibroblasts (supplementary Fig 2C
online). Overexpression of miR-200c strongly reduced cancer cell
migration and invasion into Matrigel, indicating a potential
inhibitory role in malignant tumour progression (Fig 3B; supple-
mentary Fig 2D online). On the contrary, treatment of differ-
entiated cancer cell lines HPAF2 and DLD1 with inhibitors of
miR-200c, and to a lesser extent of miR-141, resulted in a
mesenchymal transition as indicated by cell scattering, upregula-
tion of vimentin and reduced expression of E-cadherin (Fig 3C).
Knowing that the breast cancer cell line MDA-MB231, which
almost completely lost both miRNAs, is derived from a basal type
of breast cancer, we analysed various types of human breast
cancer. As predicted from using cancer cell lines, we confirmed
that basal types of breast cancers, characterized by an undiffer-
entiated phenotype and poor clinical prognosis, show reduced
expression of both miRNAs compared with the common ductal
invasive type of breast cancer (supplementary Fig 2E online).
To explain further the mechanisms by which both miRNAs
induce epithelial differentiation, we searched for putative target
genes on the basis of the predicted mRNA recognition sequence of
the conserved stem–loop sequences by using the TargetScan
search programme (Lewis et al, 2003). Notably, among the highest
scored target genes for miR-200c were ZEB1 and ZEB2, which
confirms recent findings published during the course of our work
(Hurteau et al, 2007; Gregory et al, 2008; Park et al, 2008). In
addition, a putative target of miR-141 is TGFb2, indicating that
both miRNAs are functionally linked by affecting different
members of the same EMT-inducing pathway. We further selected
the putative target factors leptin receptor and cofilin 2 because
they are known promoters of malignant tumour progression
(Attoub et al, 2000; Wang et al, 2007). The predicted miRNA
binding sites in the 30 untranslated region (UTR) were highly
conserved during evolution (Fig 4A; supplementary Fig 3A online).
We could show that overexpression of miRNAs led to reduced
expression of ZEB1, TGFb2 and the other candidate genes in
undifferentiated cancer cells (Fig 4B,C; supplementary Fig 3B
online). As predicted, miR-141 had the strongest inhibitory effect
on TGFb2 and miR-200c on ZEB1 expression, as shown by RNA
and protein levels. On the contrary, treatment of differentiated
cancer cell lines HPAF2 and MCF7 with inhibitors of miR-200c or
miR-141 resulted in a change in the expression of characteristic
genes, including an increase in ZEB1 and TGFb2 expression
(supplementary Fig 3C online). A negative regulation of ZEB1 and
TGFb2 expression by miR-200c and miR-141 was indicated after
cloning of their highly conserved, putative mRNA 30UTR target
sequences in a luciferase reporter vector. After transfection into
SW480 shZEB1 clones with reduced ZEB1 and enhanced
expression of both miRNAs, both reporters showed reduced
luciferase activity in two independent shZEB1 clones compared
with shCtl clones (Fig 4D). Overexpression of miR-141 and
miR-200c in SW480 cells led to a reduced activity of TGFb2-
30UTR and ZEB1-30UTR constructs, respectively (Fig 4E). On the
contrary, selective inhibition of miR-141 and miR-200c in SW480
shZEB1 cells by specific anti-miRNAs resulted in a selective
increase in the activity of TGFb2-30UTR and ZEB1-30UTR
constructs, respectively (supplementary Fig 3D online).
DISCUSSION
By applying a miRNA expression array screen for various human
cancer cells, we detected several miRNAs suppressed by the EMT
inducer ZEB1. The most prominent effect was on members of the
miR-200 family. ZEB1 directly suppressed transcription of two
members closely linked on human chromosome 12, miR-141 and
200c, by binding to at least two highly conserved sites in their
putative promoter. In confirmation with the data published during
the course of our work (Hurteau et al, 2007; Gregory et al, 2008;
Park et al, 2008), the detected miRNAs induced a mesenchymal to
epithelial transition (MET) and inhibited EMT, migration and
invasion of undifferentiated cancer cells. We further identified
putative target genes, which are known promoters of EMT and
malignant tumour progression. One target of miR-200c is ZEB1
itself, indicating an EMT-enhancing feedforward loop in invading
cancer cells. This regulatory loop might be stabilized further by
downregulation of miR141, as one of its putative targets is TGFb2.
There is increasing evidence that ZEB1 has crucial effects on
various processes of malignant tumour progression (Peinado et al,
2007) and promotes metastasis (Spaderna et al, 2008). In the light
of the important role of ZEB1 and other EMT inducers, such as
Snail (Olmeda et al, 2007), Twist (Yang et al, 2004) and of EMT as
a whole in tumour progression, our data, indicating that ZEB1
promotes an EMT-stabilizing feedforward loop by suppressing
specific miRNAs, add functional evidence for the molecular
mechanisms underlying these processes.
Our work addressed the clinically relevant question of how
putative tumour-suppressive miRNAs can be inactivated in cancer
progression. The fact that both the ZEB1 binding sites and the
overall structure of the miR-200c and miR-141 genes are highly
conserved in vertebrates from zebrafish to human suggests that the
tumour cells use a long-established regulatory mechanism of
miRNA expression. Moreover, the second miRNA cluster of the
miR-200 family on human chromosome 1p36 also contains highly
conserved putative ZEB1 binding sites in the upstream sequence,
indicating that the whole miR-200 family can be suppressed by
ZEB1 (supplementary Fig 3E online). In addition, both the strong
transcriptional inhibition of the two miRNAs by ZEB1 and their
putative tumour-suppressive effect were detected in tumour cell
lines of various important cancer entities, namely pancreatic,
colorectal and breast cancer. A clinical relevance is indicated by
the fact that both miRNAs are lost in the highly aggressive basal
type of breast cancer, which, in contrast to the luminal and ductal
invasive type, is poorly differentiated, shows no expression of
oestrogen and progesterone receptors, and has a worse clinical
prognosis (Sempere et al, 2007).
Both miRNAs affect the expression of different molecules,
which all work in the same proinvasive manner, as is known for
TGFb2, ZEB1, cofilin and leptin receptor. The differential function
of the two miRNAs can synergize, as they are coexpressed,
possibly through coactivation by a common promoter. The
intriguing fact is that both miRNAs inhibit members of their own
ZEB1 induces a miRNA-mediated regulatory loop
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587repressing pathway: miR-200c targets ZEB1 and miR-141 targets
TGFb2. Thus, ZEB1 becomes a crucial regulator, as its aberrant
expression in cancer might start a self-enhancing feedforward loop
by downregulating its own inhibitors miR-141 and miR-200c
(Fig 4F). Moreover, if the initial signal breaks down (for example,
tumour environmental TGFb), such a loop might as well re-
enforce expression of the miRNAs, thereby re-inducing an
epithelial phenotype. This might explain the strong phenotypic
heterogeneity often seen within individual tumours and metas-
tases. Recently, Liu et al (2008) showed that ZEB1 is crucial for
TGFb-mediated EMT in various steps of organ development.
This important role of ZEB1 points out that the predicted
regulatory loop might also have a physiological role in separating
mesenchymal from epithelial tissue in development and
organogenesis.
In conclusion, we suggest that ZEB1 is a crucial promoter of
tumour progression by reducing transcription of both mRNAs and
miRNAs. Thus, ZEB1 is a central molecular regulator of a miRNA-
mediated feedforward loop, which can re-enforce EMT.
METHODS
miRNA expression microarray screen. A5 0 mg portion of total
RNA including small RNAs isolated from 4 107 cells using the
Trizol reagent (Invitrogen, Carlsbad, CA, USA) was shipped to
Capital Bio (Beijing, China). An expression screening was carried
out using CapitalBio Mammalian miRNA Array V2.0 containing
743 human, rat and mouse non-redundant miRNA probes. The
microarray data have been deposited on ArrayExpress (http://
www.ebi.ac.uk/arrayexpress/) with the accession code E-TABM-461.
DNA constructs. For the hsa-miR-200c promoter reporter plas-
mid nucleotides  683 to  67, and for the spacer reporter
nucleotides þ66 to þ403 (relative to first nucleotide of
miR-200c stem–loop) were cloned into pGL3basic (Promega,
Mannheim, Germany). For the 30UTR reporter plasmids, nucleo-
tides þ3,399 to þ3,953 of human ZEB1 complementary DNA
and nucleotides þ1,427 to þ1,695 of human TGFb2 cDNA were
amplified and cloned downstream of the luciferase gene in the
pMIR-REPORT vector (Ambion, Austin, TX, USA).
Cell culture and standard assays. All cell lines were purchased
from ATCC (Manassas, VA, USA). Standard cell culture, transient
transfections, reporter assays, electromobility shift assays, immuno-
blots, transient short interfering RNA (siRNA)-mediated knockdown
and quantitative real-time reverse transcription–PCR were
carried out as described previously (Brabletz et al, 1999, 2004;
Hlubek et al, 2001). For TGFb/TNFa stimulation 3 104 cells
per well were seeded in a 12-well plate, transfected at day 1 as
indicated, and stimulated with 2ng/ml TGFb and 10ng/ml
TNFa for 5 days.
Specific assays. miRNA modulation: A total of 5 104 cells per
well were seeded in a 12-well plate. After 24h, cells were
transfected with 30pmol oligonucleotides for miR-141, miR-200c
or control miRNA-16 (Ambion, Austin, TX, USA) using
Oligofectamine
TM Reagent (Invitrogen, Carlsbad, CA, USA) for
overexpression, or with 420nM of specific anti-miRs (Ambion) for
inhibition. Cells were cultivated for days before further use. Cell
invasion was evaluated using the Chemicon Cell Invasion Assay
Kit as described previously (Chemicon International, Millipore,
Schwalbach, Germany), using 20,000 transiently (miRNA or
siRNA) transfected cells.
Cell migration assay: Cells were transfected with miRNAs and
controls as described (Spaderna et al, 2006). After reaching
confluence, cells were scratched with a pipette tip and the
migration potential was observed for up to 50h.
Quantitative real-time PCR for miRNAs: RNA from cultured cells
was extracted using the mirVana
TM PARIS
TM Kit (Ambion, Austin,
TX, USA). Total RNA of formalin-fixed, paraffin-embedded
samples of breast carcinomas retrieved from the archives of the
Department of Pathology, University of Erlangen was extracted
after microdissection using the Total Nucleic Acid Isolation Kit for
FFPE (Ambion, Austin, TX, USA). Specific quantitative real-time
PCR experiments were carried out using TaqMans MicroRNA
Assays for miR-141, miR-200c and control miRNA-16 (Applied
Biosystems, Foster City, CA, USA) on a Roche LightCycler 480.
ChIP analysis: The ChIP IT kit (Active Motif, Carlsbad, CA, USA)
was applied according to the manufacturer’s instructions. A 3mg
portion of control rabbit antiserum or antisera against ZEB1 was
used for immunoprecipitation.
For oligonucleotide sequences, plasmids and antibodies used
in this study, see the supplementary information online data.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
ACKNOWLEDGEMENTS
We thank B. Waldvogel and J. Pfannstiel for expert technical assistance.
This work was supported by grants to T.B. from the European Union
project Migrating Cancer Stem Cells contract no. 037297, the Deutsche
Forschungsgemeinschaft (no. BR 1399/4-3) and the Deutsche Krebshilfe
(no. 106958).
CONFLICT OF INTEREST
The authors declare that they have no conflict of interest.
REFERENCES
Aigner K et al (2007) The transcription factor ZEB1 (DEF1) promotes tumour
cell dedifferentiation by repressing master regulators of epithelial
polarity. Oncogene 26: 6979–6988
Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP,
Gespach C (2000) Leptin promotes invasiveness of kidney and colonic
epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent
signaling pathways. FASEB J 14: 2329–2338
Barrallo-Gimeno A, Nieto MA (2005) The Snail genes as inducers of cell
movement and survival: implications in development and cancer.
Development 132: 3151–3161
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and
function. Cell 116: 281–297
Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H,
Sheppard D, Oettgen P, Mercurio AM (2005) Transcriptional activation of
integrin b6 during the epithelial–mesenchymal transition defines a novel
prognostic indicator of aggressive colon carcinoma. J Clin Invest 115:
339–347
Berx G, Raspe E, Christofori G, Thiery JP, Sleeman JP (2007) Pre-EMTing
metastasis? Recapitulation of morphogenetic processes in cancer. Clin
Exp Metastasis 24: 587–597
Brabletz T, Jung A, Hlubek F, Lohberg C, Meiler J, Suchy U, Kirchner T (1999)
Negative regulation of CD4 expression in T cells by the transcriptional
repressor ZEB. Int Immunol 11: 1701–1708
Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart L,
Knuechel R, Kirchner T (2001) Variable b-catenin expression in
colorectal cancer indicates a tumor progression driven by the tumor
environment. Proc Natl Acad Sci USA 98: 10356–10361
Brabletz T et al (2004) Down-regulation of the homeodomain factor
Cdx2 in colorectal cancer by collagen type I: an active role for the
tumor environment in malignant tumor progression. Cancer Res 64:
6973–6977
ZEB1 induces a miRNA-mediated regulatory loop
U. Burk et al
EMBO reports VOL 9 | NO 6 | 2008 &2008EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
scientificreport
588Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T (2005) Opinion:
migrating cancer stem cells—an integrated concept of malignant tumour
progression. Nat Rev Cancer 5: 744–749
Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in
cancer. Nat Rev Cancer 6: 259–269
Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA,
Khew-Goodall Y, Goodall GJ (2008) The miR-200 family and miR-205
regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Nat Cell Biol 10: 593–601
Grooteclaes ML, Frisch SM (2000) Evidence for a function of CtBP in
epithelial gene regulation and anoikis. Oncogene 19: 3823–3828
Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T (2001) Expression of the
invasion factor laminin g2 in colorectal carcinomas is regulated by
b-catenin. Cancer Res 61: 8089–8093
Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED,
Thompson EW (2007) Epithelial–mesenchymal and mesenchymal–
epithelial transitions in carcinoma progression. J Cell Physiol 213:
374–383
Hurteau GJ, Carlson JA, Spivack SD, Brock GJ (2007) Overexpression of the
microRNA hsa-miR-200c leads to reduced expression of transcription
factor 8 and increased expression of E-cadherin. Cancer Res 67:
7972–7976
Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003)
Prediction of mammalian microRNA targets. Cell 115: 787–798
Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC (2008) Zeb1 links
epithelial–mesenchymal transition and cellular senescence.
Development 135: 579–588
Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and
metastasis initiated by microRNA-10b in breast cancer. Nature 449:
682–688
Olmeda D, Moreno-Bueno G, Flores JM, Fabra A, Portillo F, Cano A (2007)
SNAI1 is required for tumor growth and lymph node metastasis of human
breast carcinoma MDA-MB-231 cells. Cancer Res 67: 11721–11731
Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family
determines the epithelial phenotype of cancer cells by targeting the
E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894–907
Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour
progression: an alliance against the epithelial phenotype? Nat Rev Cancer
7: 415–428
Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G,
Wells W, Kauppinen S, Cole CN (2007) Altered microRNA expression
confined to specific epithelial cell subpopulations in breast cancer.
Cancer Res 67: 11612–11620
Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, Jung A,
Kirchner T, Brabletz T (2006) A transient, EMT-linked loss of basement
membranes indicates metastasis and poor survival in colorectal cancer.
Gastroenterology 131: 830–840
Spaderna S et al (2008) The transcriptional repressor ZEB1 promotes
metastasis and loss of cell polarity in cancer. Cancer Res 68: 537–544
Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL,
Massague J (2008) Endogenous human microRNAs that suppress breast
cancer metastasis. Nature 451: 147–152
Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial–
mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131–142
Wang W, Eddy R, Condeelis J (2007) The cofilin pathway in breast cancer
invasion and metastasis. Nat Rev Cancer 7: 429–440
Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C,
Savagner P, Gitelman I, Richardson A, Weinberg RA (2004) Twist, a
master regulator of morphogenesis, plays an essential role in tumor
metastasis. Cell 117: 927–939
EMBO reports is published by Nature Publishing Group
on behalf of European Molecular Biology Organization.
ThisarticleislicensedunderaCreativeCommonsAttributionLicense
<http://creativecommons.org/licenses/by/2.5/>
ZEB1 induces a miRNA-mediated regulatory loop
U. Burk et al
&2008EUROPEAN MOLECULAR BIOLOGY ORGANIZATION EMBO reports VOL 9 | NO 6 | 2008
scientificreport
589